Canadian Agency for Drugs and Technologies in Health. (2016). DNA mismatch repair deficiency tumour testing for patients with colorectal cancer Recommendations. Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. DNA Mismatch Repair Deficiency Tumour Testing for Patients with Colorectal Cancer Recommendations. Ottawa, Ontario: Canadian Agency for Drugs and Technologies in Health, 2016.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. DNA Mismatch Repair Deficiency Tumour Testing for Patients with Colorectal Cancer Recommendations. Canadian Agency for Drugs and Technologies in Health, 2016.
Precaución: Estas citas no son 100% exactas.